(CELG:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
Thomas O. Daniel M.D.
Executive Vice President and President of Research & Early Development, Celgene Corporation
|Age||Total Calculated Compensation||This person is connected to 37 board members in 2 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2012
Dr. Thomas O. Daniel, M.D., has been President of Research & Early development of Celgene Corporation since December 2006 and has been its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen Washington and ...
Corporate Headquarters*86 Morris Avenue
Summit, New Jersey 07901
Board Members Memberships*
University of Texas Southwestern Medical Center - Dallas
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Head of Human Genetic Therapies and Director|
|Stefan F. Heidenreich||Chairman of Executive Board and Chief Executive Officer|
|€2.6M||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Warren, NJ | CelgenePosted: May 20
- Basking Ridge, NJ | CelgenePosted: May 19
- California | CelgenePosted: May 19
- New Jersey |Posted: May 17